Yves Sagot
Director/Board Member bij BIOSENIC SA
Profiel
Yves Sagot was the founder of RELIEF THERAPEUTICS Holding SA, where he held the title of Chief Scientific Officer from 2016 to 2020.
He is also the founder of Sonnet BioTherapeutics CH SA. Currently, Dr. Sagot is an Independent Director at BioSenic SA since 2023.
Dr. Sagot has a graduate and doctorate degree from the University of Geneva and a doctorate degree from Université Toulouse III - Paul Sabatier.
Actieve functies van Yves Sagot
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOSENIC SA | Director/Board Member | 27-01-2023 |
Eerdere bekende functies van Yves Sagot
| Bedrijven | Functie | Einde |
|---|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Founder | 08-10-2020 |
Sonnet BioTherapeutics CH SA
 Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Founder | - |
Opleiding van Yves Sagot
| University of Geneva | Doctorate Degree |
| Université Toulouse III - Paul Sabatier | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| BIOSENIC SA | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Health Technology |
